Protein Powder Microbial Testing: What Whey and Plant-Based Brands Need From a Food Safety Testing Laboratory

Salmonella doesn’t care that your product is positioned as “clean protein” or “made from whole food sources.” Every year, it finds its way into whey concentrates, pea protein batches, and rice protein blends — and the brands that get hit are rarely ones that skipped testing entirely. They’re the ones that tested once, on a single batch, and assumed the process was stable after that.

That’s the pattern we see when protein powder brands come to us after a recall or an Amazon listing suspension. The contamination almost never materialized from nowhere. It was a supplier switch that didn’t trigger re-testing. Or a new raw material lot with a higher initial microbial load that pushed the finished product past specification after blending. Or an environmental monitoring program that existed on paper but hadn’t been run in two years.

Protein powders occupy a specific regulatory position that catches a lot of brands off guard. They’re marketed and regulated as dietary supplements under 21 CFR Part 111 — but their raw material contamination risks look much more like food safety problems. Getting that distinction right is exactly what separates brands that pass audit from brands that don’t.

Why Protein Powders Present Higher Microbial Risk Than Most Supplement Categories

The contamination risk in a protein powder isn’t in the finished product — it’s upstream, in the ingredients. And the source matters a lot.

Whey protein concentrate and isolate both originate from cheese manufacturing. That means the source environment is inherently exposed to Salmonella, E. coli, and Staphylococcus aureus — organisms that live in dairy facilities and on raw milk contact surfaces. Most reputable whey processors use heat treatment steps that reduce this burden significantly, but heat treatment alone isn’t a guarantee. Environmental persistence of Salmonella in powder-handling environments is well-documented; the organism can survive for months on dry surfaces and re-enter a product stream through post-heat contamination.

Plant-based proteins carry a different risk profile. Pea protein concentrate, rice protein, and hemp protein all originate from agricultural crops with extensive soil exposure. Processing typically involves drying steps at ambient or slightly elevated temperatures — conditions that allow residual microbial populations to survive the journey from field to bag. We consistently see higher baseline total yeast and mold counts in plant-based protein lots compared to dairy-derived proteins from the same brands. In some cases the difference exceeds a full log: 1,000 CFU/g in a pea protein lot versus 80–100 CFU/g in a comparable whey isolate lot. Both may pass specification, but the plant-based starting point leaves almost no margin before a problem lot crosses the line.

Bacillus cereus is a particular concern with plant proteins that most brands aren’t screening for. It’s a spore-forming bacterium native to agricultural soils, and its spores withstand short-duration heat treatment well above 100°C. Unlike vegetative organisms, you can’t heat-process your way out of a B. cereus problem once the spores are in the raw material. The conditions that allow spores to germinate — moisture reintroduction, temperature cycling during storage — are conditions that protein powders encounter throughout their shelf life.

What USP <61>, <62>, and 21 CFR Part 111 Actually Require

Here’s where a lot of brands get into trouble: they know they need microbial testing, they run the basics, and they think they’re covered. Let’s be specific about what “the basics” actually means — and where those basics leave gaps.

USP <61> defines the enumeration methods for total aerobic microbial count (TAMC) and total combined yeast and mold count (TYMC). For oral solid nonaqueous preparations — which is what a protein powder is — the acceptance criteria under USP <2021> set TAMC at not more than 10³ CFU/g (1,000 CFU/g) and TYMC at not more than 10² CFU/g (100 CFU/g). Those are the floor, not the ceiling. A product can pass both limits and still harbor a pathogen load sufficient to cause illness if a specified organism is present.

USP <62> covers testing for specified organisms. Salmonella species must be absent in a 10 g sample. Escherichia coli must be absent in a 1 g sample. Staphylococcus aureus must not exceed 10² CFU/g. These are the standard acceptance criteria — meeting them is a regulatory requirement, not a differentiator.

21 CFR Part 111 — FDA’s dietary supplement current good manufacturing practice regulation — adds the manufacturing accountability layer. Under §111.75, manufacturers must conduct laboratory testing to verify that each finished batch meets established finished product specifications before it’s released for distribution. The operative word is “established.” FDA doesn’t dictate what your microbial specifications must be, but it expects you to have them, to test against them, and to document that every batch was evaluated. Brands that rely entirely on their contract manufacturer’s internal testing without maintaining their own independent COA are exposed — both to FDA inspection findings and to retailer compliance actions.

The gap the specification framework doesn’t close is comprehensive pathogen surveillance. USP <61> and <62> define a minimum screen. They don’t cover Bacillus cereus, Listeria monocytogenes, or staphylococcal enterotoxins. For high-risk protein categories, those omissions are meaningful.

The Four Organisms That Show Up Most in Protein Powder Failures

Not all microbial failures are equal. Here’s what actually appears in protein powder testing failures and recall events — and why each one demands a specific response.

Salmonella is the most common pathogen in protein powder recalls. It’s a hardy organism that survives drying, tolerates low water activity, and can persist in powder-processing environments for extended periods after an initial contamination event. FDA’s recall database documents multiple protein and meal replacement powder recalls per year linked to Salmonella contamination, and the outbreaks that reach the news often involve dozens of reported illnesses across multiple states before the product is removed. The challenge for brands is that Salmonella can be present in a finished lot at levels undetectable by routine screening if the sample size is insufficient — which is why sampling plan design matters as much as test method selection.

E. coli serves dual roles in a protein powder testing program. As an indicator organism, its presence signals potential fecal contamination somewhere in the raw material supply chain — even at levels below the specification limit, it’s a red flag worth investigating. As a pathogen (specifically E. coli O157:H7), it requires confirmed absence. Finding non-pathogenic E. coli in finished protein powder should trigger raw material investigation, not just batch rejection. Something upstream introduced fecal contamination, and that source is still in the system.

Staphylococcus aureus is particularly relevant for whey-based products. Here’s the part most brands don’t know: S. aureus produces heat-stable enterotoxins that remain biologically active even after the bacteria themselves are killed by heat treatment. A whey protein lot that tests negative for S. aureus organisms can, under certain processing conditions, still carry sufficient toxin to cause illness if the contamination event occurred early in the process and temperatures weren’t high enough — or sustained long enough — to denature the toxin. Enterotoxin testing is available as a standalone assay and is warranted for high-volume whey products, particularly those produced in facilities with documented S. aureus environmental monitoring findings.

Bacillus cereus rounds out the list. It’s less commonly screened for in standard supplement testing packages, which is part of the reason it shows up in unexpected places. Standard aerobic plate count methods don’t reliably detect heat-shocked spores unless the protocol includes a specific activation step. Any food safety testing laboratory running protein powder screens should include a dedicated B. cereus method, particularly for plant-based products from suppliers in agricultural-intensive production regions.

What to Demand From Your Food Safety Testing Laboratory

The choice of testing partner matters as much as the testing itself. Not all laboratories operate under the same standards, and a COA issued by a lab that lacks proper accreditation may not hold up under a regulatory inquiry or retailer compliance audit.

ISO 17025 accreditation is the non-negotiable starting point. ISO 17025 is the international standard for testing laboratory competence — it covers method validation, equipment calibration, proficiency testing, staff qualification, and result traceability. For protein powder brands selling on Amazon, distributing through major retailers, or exporting, a COA from a non-accredited lab will frequently fail the documentation review. California-based brands have additional incentive: the California Department of Public Health takes laboratory accreditation status into account when evaluating test data during investigations and outbreak responses.

Method selection is the next question to ask. FDA’s Bacteriological Analytical Manual (BAM) provides validated methods for Salmonella, E. coli, and other pathogens in food and dietary supplement matrices. AOAC International also publishes officially recognized methods used by accredited labs. Ask your food safety testing laboratory specifically which methods they’re using for each organism, and whether those methods have been validated in a matrix comparable to yours. High-protein, high-fat formulations can interfere with certain detection assays if validation wasn’t conducted in a similar matrix — a real-world issue that affects both recovery rates and method sensitivity.

Testing frequency and scope is where brands consistently under-invest. Launch testing on a single pilot batch tells you very little about ongoing production risk. A defensible program includes identity and microbial testing on each incoming raw ingredient lot, microbial testing at the finished product stage for every production batch, and periodic environmental monitoring of blending and packaging areas. Each new raw material supplier should trigger a full qualification sequence before that ingredient enters production. A switch from one pea protein source to another is not a minor formulation change — it’s a new contamination risk profile that hasn’t been characterized yet.

COA documentation needs to satisfy whoever is going to receive it. Amazon’s third-party lab requirements specify that COAs must include the lab’s accreditation number, the specific methods used, sample identifiers traceable to production batch records, and results reported against established acceptance criteria. A COA that reads “PASS” without underlying quantitative data doesn’t satisfy a compliance hold. We’ve reviewed documents where brands thought they were fully covered — the paperwork existed, the tests had been run — but the format wasn’t sufficient for Amazon’s review process because the method references were missing or the accreditation number wasn’t on the document.

The biggest gap we see isn’t in brands that skip testing entirely. It’s in brands that test once at launch and assume nothing changes when they switch raw material suppliers, scale up production volume, or add a co-manufacturer. Each of those events resets the contamination risk clock. Build that assumption into your testing program from the start, and work with a food safety testing laboratory that understands protein matrices well enough to help you design a sampling plan proportionate to your actual risk — not just one that checks the compliance boxes.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• Raw Ingredient Qualification and COA Verification for Dietary Supplements — Ayah Labs provides raw material testing and supplier qualification services for supplement and food ingredient buyers worldwide.
• FDA 21 CFR Part 111 GMP Compliance and Audit Readiness — Aurora TIC offers regulatory consulting for dietary supplement manufacturers navigating FDA cGMP requirements and pre-inspection preparation.
• Dietary Supplement Testing for Canadian Market Entry — Androxa supports Health Canada NHP compliance with accredited microbial and chemistry testing for supplement brands entering the Canadian market.